As the FDA adjusts to life without…
As the FDA adjusts to life without Marty Makary, M.D., [...]
As the FDA adjusts to life without Marty Makary, M.D., [...]
Kura Oncology has published early data on darlifarnib in combination [...]
Recorded at Fierce Biotech Week in Boston, this episode of [...]
It’s been more than four years since Novartis shook up [...]
OSE Immunotherapeutics has shared phase 2 data on its neo-epitope [...]
A phase 2b trial of Biogen and Denali Therapeutics’ Parkinson’s [...]
Stephen Hahn, M.D., who served as the commissioner of the [...]
Eli Lilly is laying the groundwork for a phase 2 [...]
As Eli Lilly looks to hold its lead in the [...]
Cancer immunotherapy company Liminatus Pharma has agreed to pay out [...]